Micreos
PrivateLast Round
Early Funding
Oct 25, 2022
Total Funding Raised
$108.94M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Micreos operates in Healthcare & Life Sciences and is based in Zug. Its latest recorded funding round was an Early Funding round in October 2022.
Micreos is a biotechnology company that discovers and develops recombinant proteins for chronic dermatology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, D2C Brands, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Micreos Comparables
Compare Micreos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GangaGen | 77% | |
| Lysando AG | 77% | |
| Intralytix, Inc. | 77% |
For institutional investors. Book with your work email.
Micreos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 25, 2022 | ||||
| Early Funding | Sep 30, 2021 | ||||
| Early Funding | Mar 29, 2019 | ||||
| Early Funding | Feb 18, 2016 | ||||
| Strategic | May 23, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Micreos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Altria Ventures | Strategic |
| Ministry of Economic Affairs and Climate Policy of The Netherlands | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 916% MoM, from 642 to 6.5K.
- Jul 20, 2026
Open roles increased from 0 to 83, representing 415% of headcount.
For institutional investors. Book with your work email.
Micreos Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Micreos's valuation, stock price, and market status.
Is Micreos a public or private company?
Micreos is a private company.
What is the current stock price of Micreos?
Micreos is a private company, so its shares have no public market price. Caplight tracks Micreos's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Micreos worth (valuation)?
Valuation information for Micreos is not publicly available.
Can I buy Micreos stock?
Micreos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Micreos's last funding round?
Micreos's most recent funding round was Early Funding on October 25, 2022.
Who are the main investors in Micreos?
Key investors in Micreos include Altria Ventures.
Will Micreos IPO soon?
No public IPO plans have been announced for Micreos.
How can I track Micreos secondary market activity?
Caplight tracks bids, offers, and trades in Micreos's shares on secondary markets.